SAN FRANCISCO, March 27, 2017 /PRNewswire/ --
The global clinical chemistry analyzers market is expected to reach USD 16.0 billion by 2025, according to a new study by Grand View Research, Inc. The growing prevalence of chronic diseases is anticipated to be responsible for the high urgency to adopt clinical chemistry analyzers, which thereby widens the scope for growth during the forecast period. In addition, growing base of geriatric and bariatric population, which is highly susceptible to chronic diseases, is presumed to impel the demand further. Consequently, the resultant high sample volume requiring high capability analyzing devices is driving the market growth.
(Logo: http://photos.prnewswire.com/prnh/20150105/723757 )
Moreover, increasing awareness pertaining to benefits associated with these devices is also a high impact rendering driver for clinical chemistry analyzers market. Advent of advanced chemistry analyzers has resulted in improved point-of-care testing capabilities, and thus created high potential growth opportunities for the market. In addition, technological advancements in preanalytical, analytical, and post analytical stages due to analyzing devices & reagents improved their diagnostic capabilities and overall efficiency, which is predicted to propel the growth further. These advancements include advent of microchips, sensors, chemometrics, and robotics. Furthermore, consistent efforts by public as well private healthcare organizations to increase the reliability of data have rapidly engendered the integration of automated chemistry analyzers and immunoassay systems, thereby resulting in overall reduction of workload in laboratories, thus propelling the demand.
Browse full research report with TOC on "Clinical Chemistry Analyzers Market Analysis by Product (Analyzers, Reagents), By Test (BMP, Electrolyte Panel, Liver Panel, Lipid Profile, Renal Profile, Thyroid Function Profile, Specialty Chemical Tests), By End Use, And Segment Forecasts, 2014 - 2025" at: http://www.grandviewresearch.com/industry-analysis/clinical-chemistry-analyzer-market
Further key findings from the report suggest:
Browse related reports by Grand View Research:
Grand View Research has segmented the clinical chemistry analyzers market on the basis of product, test, end use, and region:
Read Our Blog: Clinical chemical analyzers: Providing new direction for growth in clinical pathology
About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.
Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415-349-0058
Toll Free: 1-888-202-9519
Email: sales@grandviewresearch.com
Share this article